Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Baker

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory applicationYong-Kang Zhang, Jacob J Plattner, Tsutomu Akama, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseasesStephen J Baker, Tsutomu Akama, Yong-Kang Zhang, et al.
Journal of Pharmaceutical Sciences|July 11, 2007
In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plateXiaoying Hui, Stephen J Baker, Ronald C Wester, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitorsYi Xia, Kathy Cao, Yasheen Zhou, et al.
Journal of Medicinal Chemistry|November 11, 2005
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenHStephen J Benkovic, Stephen J Baker, M R K Alley, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathwayThomas H Marsilje, Marc A Labroli, Michael P Hedrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine proteaseMaosheng Duan, Wieslaw Kazmierski, Renae Crosby, et al.
Science (New York, N.Y.)|June 26, 2007
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing siteFernando L Rock, Weimin Mao, Anya Yaremchuk, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 StudyEtienne F Dumont, Amanda J Oliver, Chris Ioannou, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory applicationYong-Kang Zhang, Jacob J Plattner, Tsutomu Akama, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseasesStephen J Baker, Tsutomu Akama, Yong-Kang Zhang, et al.
Journal of Pharmaceutical Sciences|July 11, 2007
In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plateXiaoying Hui, Stephen J Baker, Ronald C Wester, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitorsYi Xia, Kathy Cao, Yasheen Zhou, et al.
Journal of Medicinal Chemistry|November 11, 2005
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenHStephen J Benkovic, Stephen J Baker, M R K Alley, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathwayThomas H Marsilje, Marc A Labroli, Michael P Hedrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine proteaseMaosheng Duan, Wieslaw Kazmierski, Renae Crosby, et al.
Science (New York, N.Y.)|June 26, 2007
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing siteFernando L Rock, Weimin Mao, Anya Yaremchuk, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 StudyEtienne F Dumont, Amanda J Oliver, Chris Ioannou, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Pageof 3